000K  utf8
1100  $c2018
1500  eng
2050  urn:nbn:de:gbv:8-publ-24027
2051  10.1186/s12883-018-1111-7
3000  Bernhard, Felix P
3010  Arnold, Carina
3010  Bettecken, Kristina
3010  Hansen, Clint
3010  Hobert, Markus A
3010  Margraf, Nils G
3010  Mätzler, Walter
3010  Poli, Sven
3010  Sartor, Jennifer
3010  Schlenstedt, Christian
3010  Weber, Yvonne G
4000  Wearables for gait and balance assessment in the neurological ward - study design and first results of a prospective cross-sectional feasibility study with 384 inpatients  [Bernhard, Felix P]
4209  Deficits in gait and balance are common among neurological inpatients. Currently, assessment of these patients is mainly subjective. New assessment options using wearables may provide complementary and more objective information. In this prospective cross-sectional feasibility study performed over a four-month period, all patients referred to a normal neurology ward of a university hospital and aged between 40 and 89 years were asked to participate. Gait and balance deficits were assessed with wearables at the ankles and the lower back. Frailty, sarcopenia, Parkinsonism, depression, quality of life, fall history, fear of falling, physical activity, and cognition were evaluated with questionnaires and surveys. Eighty-two percent (n = 384) of all eligible patients participated. Of those, 39% (n = 151) had no gait and balance deficit, 21% (n = 79) had gait deficits, 11% (n = 44) had balance deficits and 29% (n = 110) had gait and balance deficits. Parkinson's disease, stroke, epilepsy, pain syndromes, and multiple sclerosis were the most common diseases. The assessment was well accepted. Our study suggests that the use of wearables for the assessment of gait and balance features in a clinical setting is feasible. Moreover, preliminary results confirm previous epidemiological data about gait and balance deficits among neurological inpatients. Evaluation of neurological inpatients with novel wearable technology opens new opportunities for the assessment of predictive, progression and treatment response markers.
4950  https://doi.org/10.1186/s12883-018-1111-7$xR$3Volltext$534
4950  https://nbn-resolving.org/urn:nbn:de:gbv:8-publ-24027$xR$3Volltext$534
4961  https://macau.uni-kiel.de/receive/publ_mods_00002402
5051  610
5550  80 and over
5550  Adult
5550  Aged
5550  Aged
5550  Cross-Sectional Studies
5550  diagnosis
5550  epidemiology
5550  epidemiology
5550  Feasibility Studies
5550  Female
5550  Gait
5550  Gait Disorders
5550  Germany
5550  Humans
5550  Inpatients
5550  Male
5550  Middle Aged
5550  Neurologic
5550  physiology
5550  physiology
5550  physiopathology
5550  Postural Balance
5550  Prospective Studies
5550  Research Design
5550  Wearable Electronic Devices